{"pageContent": "Purpose: While a family history (FH) of prostate cancer represents an established risk factor for prostate cancer diagnosis, conflicting data exist regarding the oncologic importance of FH. Herein, we evaluated the association of FH with clinicopathologic outcomes among men undergoing radical prostatectomy (RP).", "metaData": {"source": "Clinical application of in vivo treatment delivery verification based on PET/CT imaging of positron activity induced at high energy photon therapy\nhttps://pubmed.ncbi.nlm.nih.gov/23880661/"}}